- Home
- All Stock List
- NSE
- India Cements Ltd Share Price
277.00
-0.15 (-0.05%)
-
Outperforms Index
30.41%
Return (1Y)
Beaten Nifty 500 by 25.06%
-
More Volatile
3.27%
Standard Deviation (1Y)
Higher than Nifty 500 by 2.28%
-
Consistent Performer
7/12
Months
beaten Nifty 500
-
AxisDirect View
No View
385
173
News & Announcements
-
Board of India Cements approves divestment of its non-core subsidiaries and associate companies
13 days ago
Board of India Cements approves divestment of its non-core subsidiaries and associate companies
18 - Mar - 2025 12:00 | 13 days ago
The Board of India Cements at its meeting held on 18 March 2025 has approved the following:
1. Sale of its entire equity investment in Coromandel Travels (CTL), a subsidiary of the Company. Upon completion of the said sale, CTL would cease to be a subsidiary.
2. Sale of its entire equity investment in Raasi Cement (RCL), an associate of the Company.The Board also noted that ICL Financial Services (ICLFSL) and ICL Securities (ICLSL), wholly-owned subsidiaries of the Company, have approved: -
1. Sale of their entire equity investment in Raasi Cement, an associate of the Company. Upon completion of the said sale, Raasi Cement will cease to be an associate of the Company.
2. Sale of their entire equity investment in Coromandel Electric Company (CECL), a subsidiary of the Company. Upon completion of the said sale, CECL would cease to be a subsidiary of the Company. Further, Coromandel Sugars, an associate company in which CECL holds 49.99% of equity shares, would also cease to be an associate of the Company.
3. Sale of their entire equity investment in Unique Receivables Management (Unique Receivables), an associate of the Company. Upon completion of the said sale, Unique Receivables would cease to be an associate of the Company.
Powered by Capital Market - Live News
-
Volumes soar at India Cements Ltd counter
27 days ago
Schaeffler India Ltd, Astrazeneca Pharma India Ltd, Jyoti CNC Automation Ltd, Concord Biotech Ltd are among the other stocks to see a surge in volumes on NSE today, 04 March 2025.
India Cements Ltd recorded volume of 67.31 lakh shares by 14:14 IST on NSE, a 11.95 times surge over two-week average daily volume of 5.63 lakh shares. The stock gained 11.67% to Rs.286.50. Volumes stood at 7.07 lakh shares in the last session.
Schaeffler India Ltd recorded volume of 4.48 lakh shares by 14:14 IST on NSE, a 8.61 times surge over two-week average daily volume of 52060 shares. The stock gained 4.62% to Rs.3,229.90. Volumes stood at 51882 shares in the last session.
Astrazeneca Pharma India Ltd registered volume of 69196 shares by 14:14 IST on NSE, a 7.21 fold spurt over two-week average daily volume of 9598 shares. The stock rose 6.77% to Rs.7,322.60. Volumes stood at 13811 shares in the last session.
Jyoti CNC Automation Ltd saw volume of 58.85 lakh shares by 14:14 IST on NSE, a 6.73 fold spurt over two-week average daily volume of 8.74 lakh shares. The stock increased 12.75% to Rs.869.00. Volumes stood at 6.96 lakh shares in the last session.
Concord Biotech Ltd recorded volume of 7.02 lakh shares by 14:14 IST on NSE, a 5.94 times surge over two-week average daily volume of 1.18 lakh shares. The stock gained 13.87% to Rs.1,732.45. Volumes stood at 81181 shares in the last session.
Powered by Capital Market - Live News
-
India Cements to declare Quarterly Result
27 days ago
-
Volumes soar at India Cements Ltd counter
27 days ago
Schaeffler India Ltd, Astrazeneca Pharma India Ltd, Jyoti CNC Automation Ltd, Concord Biotech Ltd are among the other stocks to see a surge in volumes on NSE today, 04 March 2025.
India Cements Ltd recorded volume of 67.31 lakh shares by 14:14 IST on NSE, a 11.95 times surge over two-week average daily volume of 5.63 lakh shares. The stock gained 11.67% to Rs.286.50. Volumes stood at 7.07 lakh shares in the last session.
Schaeffler India Ltd recorded volume of 4.48 lakh shares by 14:14 IST on NSE, a 8.61 times surge over two-week average daily volume of 52060 shares. The stock gained 4.62% to Rs.3,229.90. Volumes stood at 51882 shares in the last session.
Astrazeneca Pharma India Ltd registered volume of 69196 shares by 14:14 IST on NSE, a 7.21 fold spurt over two-week average daily volume of 9598 shares. The stock rose 6.77% to Rs.7,322.60. Volumes stood at 13811 shares in the last session.
Jyoti CNC Automation Ltd saw volume of 58.85 lakh shares by 14:14 IST on NSE, a 6.73 fold spurt over two-week average daily volume of 8.74 lakh shares. The stock increased 12.75% to Rs.869.00. Volumes stood at 6.96 lakh shares in the last session.
Concord Biotech Ltd recorded volume of 7.02 lakh shares by 14:14 IST on NSE, a 5.94 times surge over two-week average daily volume of 1.18 lakh shares. The stock gained 13.87% to Rs.1,732.45. Volumes stood at 81181 shares in the last session.
Powered by Capital Market - Live News
-
India Cements to declare Quarterly Result
27 days ago
-
India Cements tanks after Q3 net loss widens to Rs 429 cr in FY25
22 - Jan - 2025 12:00 | 68 days ago
Revenue from operations stood at Rs 903.16 crore in the third quarter of FY25, down 16.51% as against Rs 1,081.88 crore posted in Q3 FY24.
The company reported a pre-tax loss of Rs 306.80 crore in Q3 FY25 as compared to a pre-tax loss of Rs 50.24 crore recorded in the same period a year ago. The firm reported exceptional items of Rs 190.26 crore during the quarter.
The company’s total expenses gained 6.23% YoY to Rs 1,220.58 crore in Q3 FY25. Employee benefits expense stood at Rs 87.22 crore (up 1.18% YoY), while finance costs stood at Rs 73.77 crore (up 23.89% YoY) during the period under review.
On a consolidated basis, the company’s net profit stood at Rs 196.22 crore in Q3 FY25, steeply higher than Rs 0.67 crore posted in Q3 FY24. Revenue from operations was at Rs 1,113.06 crore in Q3 FY25, marking a growth of 18.30% year on year.
During the quarter, the company achieved a cement capacity utilisation of 57%. Domestic sales volume grew 5% YoY.
In its outlook, India Cements said, “The company and its shareholders will benefit from synergy with its holding company with the introduction of new systems and processes, economies of scale, cost optimization, and a wider distribution network. The credit rating of the company is already enhanced to AAA and will help to bring overall cost rationalization. India Cements is poised to grow stronger with an increase in its sales, optimization of costs, and efficient operations.
With the increasing government spending on infrastructure and the improvement in demand in housing markets, the company is well-positioned to strengthen its presence in its core markets and contribute to the overall growth aspirations of the country.”
India Cements business is the manufacturing and sale of cement and cement-related products.
Powered by Capital Market - Live News
-
Board of India Cements approves divestment of its non-core subsidiaries and associate companies
13 days ago
Board of India Cements approves divestment of its non-core subsidiaries and associate companies
18 - Mar - 2025 12:00 | 13 days ago
The Board of India Cements at its meeting held on 18 March 2025 has approved the following:
1. Sale of its entire equity investment in Coromandel Travels (CTL), a subsidiary of the Company. Upon completion of the said sale, CTL would cease to be a subsidiary.
2. Sale of its entire equity investment in Raasi Cement (RCL), an associate of the Company.The Board also noted that ICL Financial Services (ICLFSL) and ICL Securities (ICLSL), wholly-owned subsidiaries of the Company, have approved: -
1. Sale of their entire equity investment in Raasi Cement, an associate of the Company. Upon completion of the said sale, Raasi Cement will cease to be an associate of the Company.
2. Sale of their entire equity investment in Coromandel Electric Company (CECL), a subsidiary of the Company. Upon completion of the said sale, CECL would cease to be a subsidiary of the Company. Further, Coromandel Sugars, an associate company in which CECL holds 49.99% of equity shares, would also cease to be an associate of the Company.
3. Sale of their entire equity investment in Unique Receivables Management (Unique Receivables), an associate of the Company. Upon completion of the said sale, Unique Receivables would cease to be an associate of the Company.
Powered by Capital Market - Live News
-
Volumes soar at India Cements Ltd counter
27 days ago
Schaeffler India Ltd, Astrazeneca Pharma India Ltd, Jyoti CNC Automation Ltd, Concord Biotech Ltd are among the other stocks to see a surge in volumes on NSE today, 04 March 2025.
India Cements Ltd recorded volume of 67.31 lakh shares by 14:14 IST on NSE, a 11.95 times surge over two-week average daily volume of 5.63 lakh shares. The stock gained 11.67% to Rs.286.50. Volumes stood at 7.07 lakh shares in the last session.
Schaeffler India Ltd recorded volume of 4.48 lakh shares by 14:14 IST on NSE, a 8.61 times surge over two-week average daily volume of 52060 shares. The stock gained 4.62% to Rs.3,229.90. Volumes stood at 51882 shares in the last session.
Astrazeneca Pharma India Ltd registered volume of 69196 shares by 14:14 IST on NSE, a 7.21 fold spurt over two-week average daily volume of 9598 shares. The stock rose 6.77% to Rs.7,322.60. Volumes stood at 13811 shares in the last session.
Jyoti CNC Automation Ltd saw volume of 58.85 lakh shares by 14:14 IST on NSE, a 6.73 fold spurt over two-week average daily volume of 8.74 lakh shares. The stock increased 12.75% to Rs.869.00. Volumes stood at 6.96 lakh shares in the last session.
Concord Biotech Ltd recorded volume of 7.02 lakh shares by 14:14 IST on NSE, a 5.94 times surge over two-week average daily volume of 1.18 lakh shares. The stock gained 13.87% to Rs.1,732.45. Volumes stood at 81181 shares in the last session.
Powered by Capital Market - Live News
-
India Cements to declare Quarterly Result
27 days ago
-
India Cements tanks after Q3 net loss widens to Rs 429 cr in FY25
22 - Jan - 2025 12:00 | 68 days ago
Revenue from operations stood at Rs 903.16 crore in the third quarter of FY25, down 16.51% as against Rs 1,081.88 crore posted in Q3 FY24.
The company reported a pre-tax loss of Rs 306.80 crore in Q3 FY25 as compared to a pre-tax loss of Rs 50.24 crore recorded in the same period a year ago. The firm reported exceptional items of Rs 190.26 crore during the quarter.
The company’s total expenses gained 6.23% YoY to Rs 1,220.58 crore in Q3 FY25. Employee benefits expense stood at Rs 87.22 crore (up 1.18% YoY), while finance costs stood at Rs 73.77 crore (up 23.89% YoY) during the period under review.
On a consolidated basis, the company’s net profit stood at Rs 196.22 crore in Q3 FY25, steeply higher than Rs 0.67 crore posted in Q3 FY24. Revenue from operations was at Rs 1,113.06 crore in Q3 FY25, marking a growth of 18.30% year on year.
During the quarter, the company achieved a cement capacity utilisation of 57%. Domestic sales volume grew 5% YoY.
In its outlook, India Cements said, “The company and its shareholders will benefit from synergy with its holding company with the introduction of new systems and processes, economies of scale, cost optimization, and a wider distribution network. The credit rating of the company is already enhanced to AAA and will help to bring overall cost rationalization. India Cements is poised to grow stronger with an increase in its sales, optimization of costs, and efficient operations.
With the increasing government spending on infrastructure and the improvement in demand in housing markets, the company is well-positioned to strengthen its presence in its core markets and contribute to the overall growth aspirations of the country.”
India Cements business is the manufacturing and sale of cement and cement-related products.
Powered by Capital Market - Live News
-
Board of India Cements approves divestment of its non-core subsidiaries and associate companies
13 days ago
Board of India Cements approves divestment of its non-core subsidiaries and associate companies
18 - Mar - 2025 12:00 | 13 days ago
The Board of India Cements at its meeting held on 18 March 2025 has approved the following:
1. Sale of its entire equity investment in Coromandel Travels (CTL), a subsidiary of the Company. Upon completion of the said sale, CTL would cease to be a subsidiary.
2. Sale of its entire equity investment in Raasi Cement (RCL), an associate of the Company.The Board also noted that ICL Financial Services (ICLFSL) and ICL Securities (ICLSL), wholly-owned subsidiaries of the Company, have approved: -
1. Sale of their entire equity investment in Raasi Cement, an associate of the Company. Upon completion of the said sale, Raasi Cement will cease to be an associate of the Company.
2. Sale of their entire equity investment in Coromandel Electric Company (CECL), a subsidiary of the Company. Upon completion of the said sale, CECL would cease to be a subsidiary of the Company. Further, Coromandel Sugars, an associate company in which CECL holds 49.99% of equity shares, would also cease to be an associate of the Company.
3. Sale of their entire equity investment in Unique Receivables Management (Unique Receivables), an associate of the Company. Upon completion of the said sale, Unique Receivables would cease to be an associate of the Company.
Powered by Capital Market - Live News
-
Volumes soar at India Cements Ltd counter
27 days ago
Schaeffler India Ltd, Astrazeneca Pharma India Ltd, Jyoti CNC Automation Ltd, Concord Biotech Ltd are among the other stocks to see a surge in volumes on NSE today, 04 March 2025.
India Cements Ltd recorded volume of 67.31 lakh shares by 14:14 IST on NSE, a 11.95 times surge over two-week average daily volume of 5.63 lakh shares. The stock gained 11.67% to Rs.286.50. Volumes stood at 7.07 lakh shares in the last session.
Schaeffler India Ltd recorded volume of 4.48 lakh shares by 14:14 IST on NSE, a 8.61 times surge over two-week average daily volume of 52060 shares. The stock gained 4.62% to Rs.3,229.90. Volumes stood at 51882 shares in the last session.
Astrazeneca Pharma India Ltd registered volume of 69196 shares by 14:14 IST on NSE, a 7.21 fold spurt over two-week average daily volume of 9598 shares. The stock rose 6.77% to Rs.7,322.60. Volumes stood at 13811 shares in the last session.
Jyoti CNC Automation Ltd saw volume of 58.85 lakh shares by 14:14 IST on NSE, a 6.73 fold spurt over two-week average daily volume of 8.74 lakh shares. The stock increased 12.75% to Rs.869.00. Volumes stood at 6.96 lakh shares in the last session.
Concord Biotech Ltd recorded volume of 7.02 lakh shares by 14:14 IST on NSE, a 5.94 times surge over two-week average daily volume of 1.18 lakh shares. The stock gained 13.87% to Rs.1,732.45. Volumes stood at 81181 shares in the last session.
Powered by Capital Market - Live News
-
India Cements to declare Quarterly Result
27 days ago
-
Volumes soar at India Cements Ltd counter
27 days ago
Schaeffler India Ltd, Astrazeneca Pharma India Ltd, Jyoti CNC Automation Ltd, Concord Biotech Ltd are among the other stocks to see a surge in volumes on NSE today, 04 March 2025.
India Cements Ltd recorded volume of 67.31 lakh shares by 14:14 IST on NSE, a 11.95 times surge over two-week average daily volume of 5.63 lakh shares. The stock gained 11.67% to Rs.286.50. Volumes stood at 7.07 lakh shares in the last session.
Schaeffler India Ltd recorded volume of 4.48 lakh shares by 14:14 IST on NSE, a 8.61 times surge over two-week average daily volume of 52060 shares. The stock gained 4.62% to Rs.3,229.90. Volumes stood at 51882 shares in the last session.
Astrazeneca Pharma India Ltd registered volume of 69196 shares by 14:14 IST on NSE, a 7.21 fold spurt over two-week average daily volume of 9598 shares. The stock rose 6.77% to Rs.7,322.60. Volumes stood at 13811 shares in the last session.
Jyoti CNC Automation Ltd saw volume of 58.85 lakh shares by 14:14 IST on NSE, a 6.73 fold spurt over two-week average daily volume of 8.74 lakh shares. The stock increased 12.75% to Rs.869.00. Volumes stood at 6.96 lakh shares in the last session.
Concord Biotech Ltd recorded volume of 7.02 lakh shares by 14:14 IST on NSE, a 5.94 times surge over two-week average daily volume of 1.18 lakh shares. The stock gained 13.87% to Rs.1,732.45. Volumes stood at 81181 shares in the last session.
Powered by Capital Market - Live News
-
India Cements to declare Quarterly Result
27 days ago
-
India Cements tanks after Q3 net loss widens to Rs 429 cr in FY25
22 - Jan - 2025 12:00 | 68 days ago
Revenue from operations stood at Rs 903.16 crore in the third quarter of FY25, down 16.51% as against Rs 1,081.88 crore posted in Q3 FY24.
The company reported a pre-tax loss of Rs 306.80 crore in Q3 FY25 as compared to a pre-tax loss of Rs 50.24 crore recorded in the same period a year ago. The firm reported exceptional items of Rs 190.26 crore during the quarter.
The company’s total expenses gained 6.23% YoY to Rs 1,220.58 crore in Q3 FY25. Employee benefits expense stood at Rs 87.22 crore (up 1.18% YoY), while finance costs stood at Rs 73.77 crore (up 23.89% YoY) during the period under review.
On a consolidated basis, the company’s net profit stood at Rs 196.22 crore in Q3 FY25, steeply higher than Rs 0.67 crore posted in Q3 FY24. Revenue from operations was at Rs 1,113.06 crore in Q3 FY25, marking a growth of 18.30% year on year.
During the quarter, the company achieved a cement capacity utilisation of 57%. Domestic sales volume grew 5% YoY.
In its outlook, India Cements said, “The company and its shareholders will benefit from synergy with its holding company with the introduction of new systems and processes, economies of scale, cost optimization, and a wider distribution network. The credit rating of the company is already enhanced to AAA and will help to bring overall cost rationalization. India Cements is poised to grow stronger with an increase in its sales, optimization of costs, and efficient operations.
With the increasing government spending on infrastructure and the improvement in demand in housing markets, the company is well-positioned to strengthen its presence in its core markets and contribute to the overall growth aspirations of the country.”
India Cements business is the manufacturing and sale of cement and cement-related products.
Powered by Capital Market - Live News
Stock Trivia
India Cements Ltd has been the 3rd best in 1 years performance among stocks in Cement Sector
Promoter shareholding in India Cements Ltd has increased by 95.24% since past 3 Months
India Cements Ltd has been the 3rd best in 1 years performance among stocks in Cement Sector
FII shareholding in India Cements Ltd has decreased by -10.28% since past 3 Months
MF shareholding in India Cements Ltd has increased by 38.61% since past 3 Months
Promoter shareholding in India Cements Ltd has increased by 95.24% since past 3 Months
India Cements Ltd has been the 3rd best in 1 years performance among stocks in Cement Sector
Promoter shareholding in India Cements Ltd has increased by 95.24% since past 3 Months
